Following GEN – Genetic Engineering and Biotechnology News's news feed is very easy. Subscribe using the "follow" button on the top right and if you want to, choose the updates by topic or tag.
We will deliver them to your inbox, your phone, or you can use follow.it like your own online RSS reader. You can unsubscribe whenever you want with one click.
Keep up to date with GEN – Genetic Engineering and Biotechnology News!
GEN – Genetic Engineering and Biotechnology News: GEN Homepage - GEN - Genetic Engineering and Biotechnology News
Is this your feed? Claim it!
Nucleus Biologics launched the Krakatoa® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand and at point-of-use. The system enables the co-location of cell culture media and buffer manufacturing and bioproduction.
The Krakatoa K500 supports biologics manuf...
Women in Science Day (February 11) was the top of the list for discussion for GEN editors in this week’s podcast. They shared an anecdote on the history of the term “scientist”—hint: it was coined for a woman. A modern scientist, Medra CEO Michelle Lee, PhD, discussed with GEN how the company is integrating robotics with AI for use in biological research.
Biologists often say that structure determines function. In a new study, Northwestern University researchers show that this principle applies not only to proteins but may also to cancer vaccines—where the nanoscale arrangement of a single peptide can dramatically alter therapeutic potency. By re‑engineering the orientation of an HPV‑derived antigen on a spherical nucleic acid...
Researchers headed by a team at the University of Pennsylvania have found that exercise does more than strengthen muscles, it also rewires the brain. Studying mice, the investigators discovered that the lasting gain in endurance from repeated exercise—such as the ability to run farther and faster over time—involves changes in brain activity that help muscles an...
Jacob Berlin, PhD, CEO of Terray Therapeutics, explains that the critical element to “get right” for a preclinical drug discovery campaign is identifying molecules that rank best among the candidate set.
The AI drug discovery company is building an end-to-end pipeline to bring novel small molecule drugs from unseen chemical space to the ...